Prognostic factors for the outcome of Bells' palsy: A cohort register-based study
- PMID: 32395899
- DOI: 10.1111/coa.13571
Prognostic factors for the outcome of Bells' palsy: A cohort register-based study
Abstract
Objectives: There is a lack of data on patients' and diagnostic factors for prognostication of complete recovery in patients with Bell's palsy.
Design and setting: Cohort register-based study of 368 patients with Bell's palsy and uniform diagnostics and standardised treatment in a university hospital from 2007 to 2017 (49% female, median age: 51 years).
Main outcome measures: Clinical data, facial grading, electrodiagnostics, motor function tests, non-motor function tests and onset of prednisolone therapy were assessed for their impact on the probability of complete recovery using univariable and multivariable statistics.
Results: Median onset of treatment was 1.5 days. 46% of patients had a House-Brackmann scale at baseline of ≥ III. The median recovery time was 2.6 months (95% confidence interval [CI] = 2.1-3.0). 54.9% achieved a complete recovery. If prednisolone therapy started later than 96 hours after onset, the recovery rate decreased significantly. Beyond less severe palsy, no abnormal electroneurography side difference, no pathological spontaneous activity in electromyography and normal stapedius reflex testing were the most powerful tool for prognostication of recovery after Bell's palsy.
Conclusion: Beyond severity of the palsy, facial electrodiagnostics and stapedius reflex testing are the most powerful tool for prognostication of recovery time after Bell's palsy. Prednisolone therapy should have started at best within a time window of 96 hours after onset to reach the highest probability of complete recovery.
Keywords: electrodiagnostics; facial nerve; paralysis; paresis; prognosis; recovery; stapedius reflex.
© 2020 The Authors. Clinical Otolaryngology published by John Wiley & Sons Ltd.
References
REFERENCES
-
- Gilden DH. Clinical practice. Bell's Palsy. N Engl J Med. 2004;351(13):1323-1331.
-
- Gronseth GS, Paduga R. American Academy of N. Evidence-based guideline update: steroids and antivirals for Bell palsy: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2012;79(22):2209-2213.
-
- Baugh RF, Basura GJ, Ishii LE, et al. Clinical practice guideline: Bell's palsy. Otolaryngol Head Neck Surg. 2013;149(3 Suppl):S1-S27.
-
- Heckmann JG, Urban PP, Pitz S, Guntinas-Lichius O, Gagyor I. The diagnosis and treatment of idiopathic facial paresis (Bell's Palsy). Dt Arztebl Int. 2019;116(41):692-702.
-
- Sullivan FM, Swan IR, Donnan PT, et al. Early treatment with prednisolone or acyclovir in Bell's palsy. N Engl J Med. 2007;357(16):1598-1607.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
